ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

NCA Okays New Centers Category For Environmental Carcinogenesis

July 4, 1975